Pre-session administration of d-cycloserine DCS has been found to augment exposure therapy outcomes in a variety of anxiety disorders. To be able to enhance learning only for successful exposure sessions it would be beneficial to have the option of administering DCS after rather than before the session a strategy encouraged by pre-clinical work. We believe the present study is the first published report on the efficacy of post-session administration of DCS in humans. Augmentation of exposure therapy with post-session administration of D-cycloserine.